Medical Research

Hørsholm, Denmark -- Today, the Market Development Fund, announced that it will support Visiopharm’s validation of its novel solutions for cancer diagnostics at seven Danish Hospitals and three international Hospitals. Visiopharm’s...

This month's issue of Archives of Pathology and Laboratory Medicine has an article entitled “Pulmonary Large Cell Carcinoma Lacking Sqaumous Differentiation Is Clinicopathologically Indistinguishable From Solid-Subtype Adenocarcinoma”...

Source: Wall Street Journal I do not usually have or make any comments on press releases re-posted but this one is worth commenting upon.  First public news I am aware of from DigiPath in about six months includes note of a new president of...

</body> PathXL will be exhibiting at Pathology Informatics Pittsburgh, PA from Tuesday May 13th – Friday May 16th. PathXL invite you to join us at table #12 where you can meet our Sales and Business Development Director North...

</body> Date: Thursday May 15th Time: 4:00 pm GMT (UK) | 11:00 am EST PathXL’s proprietary tumor detection software, TissueMark®, has been evolving rapidly since its launch in November 2013 and we are glad to announce a range of...

OR

platinum partners

gold partners

Silver Partners

Media Partners